- Home
- RAMP vs LIVN Comparison
RAMP vs LIVN Comparison
Compare RAMP & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAMP
- LIVN
- Stock Information
- Founded
- RAMP 2018
- LIVN 1987
- Country
- RAMP United States
- LIVN United Kingdom
- Employees
- RAMP N/A
- LIVN N/A
- Industry
- RAMP EDP Services
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RAMP Technology
- LIVN Health Care
- Exchange
- RAMP Nasdaq
- LIVN Nasdaq
- Market Cap
- RAMP 1.8B
- LIVN 2.1B
- IPO Year
- RAMP 1987
- LIVN 1993
- Fundamental
- Price
- RAMP $26.78
- LIVN $54.53
- Analyst Decision
- RAMP Buy
- LIVN Strong Buy
- Analyst Count
- RAMP 7
- LIVN 7
- Target Price
- RAMP $39.00
- LIVN $59.71
- AVG Volume (30 Days)
- RAMP 620.0K
- LIVN 583.7K
- Earning Date
- RAMP 11-05-2025
- LIVN 10-29-2025
- Dividend Yield
- RAMP N/A
- LIVN N/A
- EPS Growth
- RAMP 147.00
- LIVN N/A
- EPS
- RAMP 0.22
- LIVN N/A
- Revenue
- RAMP $764,441,000.00
- LIVN $1,309,329,000.00
- Revenue This Year
- RAMP $10.65
- LIVN $11.29
- Revenue Next Year
- RAMP $8.70
- LIVN $6.59
- P/E Ratio
- RAMP $123.53
- LIVN N/A
- Revenue Growth
- RAMP 12.16
- LIVN 8.23
- 52 Week Low
- RAMP $22.82
- LIVN $32.48
- 52 Week High
- RAMP $36.08
- LIVN $58.91
- Technical
- Relative Strength Index (RSI)
- RAMP 42.52
- LIVN 50.60
- Support Level
- RAMP $26.15
- LIVN $56.42
- Resistance Level
- RAMP $27.08
- LIVN $57.53
- Average True Range (ATR)
- RAMP 0.68
- LIVN 1.35
- MACD
- RAMP 0.06
- LIVN -0.70
- Stochastic Oscillator
- RAMP 24.42
- LIVN 10.25
About RAMP LiveRamp Holdings Inc.
LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.